Company intelligence / Profile preview

Singular Genomics

San Diego, California, United Statessingulargenomics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Singular Genomics develops and commercializes next-generation sequencing platforms with a focus on high-throughput multiomic spatial biology. Their flagship products enable rapid genomic and proteomic profiling of tissue samples at subcellular resolution. The company’s technologies are used by academic researchers and biopharma partners to advance precision diagnostics and translational medicine. No direct clinical results as they do not develop therapeutics themselves.

Therapeutic areas: Other
Modalities: Device (sequencing platform)Multiomic analysis technologyNot directly therapeutic; enables research in DNA, RNA, protein analysis
Industry: Molecular Diagnostics

Partnerships

Sanford Burnham Prebys Medical Discovery Institute (customer)Fate Therapeutics (customer)

Beyond the preview

Go deeper on Singular Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Singular Genomics.

Explore the full profile